secwatch.observer — SEC 8-K summary
======================================

Issuer:     Pediatrix Medical Group, Inc. (MD)
CIK:        0000893949
Form:       8-K
Filed at:   2025-02-20T23:59:59+00:00
Accession:  0000950170-25-023723
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Pediatrix Q4 net income $30M, Adjusted EPS $0.51, revenue up to $502M
---------------------------------------------------------------------

- GAAP EPS $0.36 (vs $1.50 loss Q4 2023); Adjusted EPS $0.51 (vs $0.32).
- Net revenue $502M, up from $496M; same-unit revenue grew 8.7%.
- Adjusted EBITDA $68.7M (vs $50.8M); portfolio restructuring completed by Dec 31, 2024.
- Preliminary 2025 Adjusted EBITDA guidance $215M-$235M.
- Cash from operations $134.8M; total debt $616M; no revolver borrowings.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/893949/000095017025023723/0000950170-25-023723-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/893949/000095017025023723/md-20250220.htm
  HTML page:      https://secwatch.observer/filing/0000950170-25-023723

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer